Biallelic loss-of-function variations in PRDX3 cause cerebellar ataxia
Open Access
- 23 April 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 144 (5) , 1467-1481
Abstract
Peroxiredoxin 3 (PRDX3) belongs to a superfamily of peroxidases that function as protective antioxidant enzymes. Among the six isoforms (PRDX1–PRDX6), PRDX3 is the only protein exclusively localized to the mitochondria, which are the main source of reactive oxygen species. Excessive levels of reactive oxygen species are harmful to cells, inducing mitochondrial dysfunction, DNA damage, lipid and protein oxidation and ultimately apoptosis. Neuronal cell damage induced by oxidative stress has been associated with numerous neurodegenerative disorders including Alzheimer’s and Parkinson’s diseases. Leveraging the large aggregation of genomic ataxia datasets from the PREPARE (Preparing for Therapies in Autosomal Recessive Ataxias) network, we identified recessive mutations in PRDX3 as the genetic cause of cerebellar ataxia in five unrelated families, providing further evidence for oxidative stress in the pathogenesis of neurodegeneration. The clinical presentation of individuals with PRDX3 mutations consists of mild-to-moderate progressive cerebellar ataxia with concomitant hyper- and hypokinetic movement disorders, severe early-onset cerebellar atrophy, and in part olivary and brainstem degeneration. Patient fibroblasts showed a lack of PRDX3 protein, resulting in decreased glutathione peroxidase activity and decreased mitochondrial maximal respiratory capacity. Moreover, PRDX3 knockdown in cerebellar medulloblastoma cells resulted in significantly decreased cell viability, increased H2O2 levels and increased susceptibility to apoptosis triggered by reactive oxygen species. Pan-neuronal and pan-glial in vivo models of Drosophila revealed aberrant locomotor phenotypes and reduced survival times upon exposure to oxidative stress. Our findings reveal a central role for mitochondria and the implication of oxidative stress in PRDX3 disease pathogenesis and cerebellar vulnerability and suggest targets for future therapeutic approaches.Keywords
Funding Information
- European Union’s Horizon 2020 Research and Innovation Program (01GM1607, 779257)
- Solve-RD
- Association Connaitre les Syndromes Cérébelleux
- European Reference Network for Rare Neurological Diseases (739510)
This publication has 42 references indexed in Scilit:
- Autosomal Recessive Cerebellar Ataxias: Paving the Way toward Targeted Molecular TherapiesNeuron, 2019
- SnapShot: Biology of Genetic AtaxiasCell, 2018
- Recessive ataxias2018
- Epidemiology of Cerebellar Diseases and Therapeutic ApproachesThe Cerebellum, 2017
- Cerebellar Ataxia in Patients With Mitochondrial DNA DiseaseJournal of Neuropathology & Experimental Neurology, 2012
- Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approachesHuman Molecular Genetics, 2010
- ATAXIA WITH OPHTHALMOPLEGIA OR SENSORY NEUROPATHY IS FREQUENTLY CAUSED BY POLG MUTATIONSNeurology, 2009
- Friedreich ataxia: the oxidative stress paradoxHuman Molecular Genetics, 2004
- Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxiaAnnals of Neurology, 2001
- Pathophysiology of cerebellar ataxiaMovement Disorders, 1992